Research output per year
Research output per year
Research output
- 7 Article
Search results
-
2023
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer
Rijnders, M., Robbrecht, D. G. J., Oostvogels, A. A. M., van Brakel, M., Boormans, J. L., Aarts, M. J. B., Balcioglu, H. E., Hamberg, P., Voortman, J., Westgeest, H. M., Lolkema, M. P., de Wit, R., van der Veldt, A. A. M. & Debets, R., Mar 2023, In: Cancer Immunology Immunotherapy. 72, 3, p. 759-767 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Downloads (Pure) -
2022
Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8þ T cells
Rijnders, M., Balcioglu, H. E., Robbrecht, D. G. J., Oostvogels, A. A. M., Wijers, R., Aarts, M. J. B., Hamberg, P., van Leenders, G. J. L. H., Nakauma-González, J. A., Voortman, J., Westgeest, H. M., Boormans, J. L., de Wit, R., Lolkema, M. P., van der Veldt, A. A. M. & Debets, R., 1 Jan 2022, In: Clinical Cancer Research. 28, 1, p. 215-226 12 p.Research output: Contribution to journal › Article › Academic › peer-review
2 Citations (Scopus) -
Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program
El Haddaoui, H., Brood, R., Latifi, D., Oostvogels, A. A., Klaver, Y., Moskie, M., Mustafa, D. A., Debets, R. & van Eijck, C. H. J., 1 Mar 2022, In: Cancers. 14, 6, 1377.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
van der Sijde, F., Dik, W. A. A., Mustafa, D. A. M., Vietsch, E. E. E., Besselink, M. G. G., Debets, R., Koerkamp, B. G., Haberkorn, B. C. M., Homs, M. Y. V., Janssen, Q. P. P., Luelmo, S. A. C., Mekenkamp, L. J. M., Oostvogels, A. A. M., Smits-te Nijenhuis, M. A. W., Wilmink, J. W. W. & van Eijck, C. H. J., 25 Aug 2022, In: Frontiers in Immunology. 13, 12 p., 898498.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)30 Downloads (Pure) -
2021
Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition
de Joode, K., Oostvogels, A., Geurts van Kessel, C., de Vries, R., Mathijssen, R., Debets, R. & van der Veldt, A., 4 Feb 2021, In: Frontiers in Immunology. 12, 627186.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)6 Downloads (Pure) -
2020
Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
Klaver, Y., Rijnders, M., Oostvogels, A., Wijers, R., Smid, M., Grünhagen, D., Verhoef, C., Sleijfer, S., Lamers, C. & Debets, R., 13 Aug 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, e000271.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile17 Citations (Scopus)11 Downloads (Pure) -
2019
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
Kunert, A., Basak, E. A., Hurkmans, D. P., Balcioglu, H. E., Klaver, Y., Van Brakel, M., Oostvogels, A. A. M., Lamers, C. H. J., Bins, S., Koolen, S. L. W., Van Der Veldt, A. A. M., Sleijfer, S., Mathijssen, R. H. J., Aerts, J. G. J. V. & Debets, R., 8 Jun 2019, In: Journal for ImmunoTherapy of Cancer. 7, 1, 149.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile30 Citations (Scopus)7 Downloads (Pure)